Hematology

Catherine Glass chats with Rob Pieters, Professor of Pediatric Oncology and co-founder of the Princess Máxima Center, Europe’s largest childhood cancer center.

What are myeloproliferative neoplasms, and what can research reveal about future therapies? Andrew Dunbar explores the biology, resistance, and emerging treatment strategies.

Emanuele Angelucci shares the latest on cellular therapies, gene therapy, and breakthroughs in treating haemoglobinopathies.

Steven Okoli, Honorary Senior Clinical Lecturer at Imperial College London, shares how AI, advocacy, and stem cell trials are driving the next chapter in sickle cell care.

Claudio Cerchione explores advances in multiple myeloma, MRD, and CAR-T therapy, with key insights from EHA and ASCO in this Hema Now episode.

Kevin Rouault-Pierre and Onima Chowdhury explore the molecular roots of myelodysplastic syndromes (MDS), and their implications for future care.

Lydia Scarfò discusses types of leukaemia, current treatment approaches, recent advances, and future possibilities.

Rafael Fonseca, Consultant, Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA